Archive March 9, 2022 Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
Archive February 8, 2022 Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
Archive February 1, 2022 Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call and Webcast on February 8, 2022
Archive January 24, 2022 Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session
Archive January 10, 2022 Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate Milestones
Archive January 3, 2022 Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
Archive December 21, 2021 Deciphera Announces Approval of QINLOCK® in the United Kingdom for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Archive November 30, 2021 Deciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial Operations
Archive November 22, 2021 Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
